Marc Penn
Program Director, Cardiovascular Disease Fellowship · Summa Health System
Credentials: · · · · · ·
History
- Present
Cardiovascular Disease Fellowship · Summa Health System
- Present
Cardiovascular Medicine Fellowship · Baylor College of Medicine
- Present
- 1997–2000
Cardiovascular Disease
- 1994–1997
Internal Medicine
Research
The Lancet · 2003 · Last of 12 authors · 1,033 citations
Prognostic value of myeloperoxidase in patients with chest pain
New England Journal of Medicine · 2003 · 807 citations
Systematic review or meta-analysis · The Lancet · 2003 · 732 citations
23 papers
18 papers · 2 as a fellow
15 papers
- NM
14 papers · 8 as a resident
12 papers
11 papers
- AL
9 papers
8 papers
Grants
- 2016–2024
National Heart, Lung, and Blood Institute · R44
PI · $1.9M · Madeleine Pharmaceuticals, Inc.
- 2013–2018
Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for
National Heart, Lung, and Blood Institute · R44
PI · $2M · Athersys, Inc.
- 2005–2010
Myocardial Regeneration in Ischemic Cardiomyopathy
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.8M · Cleveland Clinic Lerner Com-Cwru
- 2004–2009
Oxidation in Inflammation and Cardiovascular Disease
National Heart, Lung, and Blood Institute · P01
Project lead · $532.1K · Cleveland Clinic Lerner Com-Cwru
Clinical trials
- 2015–2020
Principal investigator · Terminated · Phase 2
Healios K.K.
- 2008–2012
Safety Study of AMI MultiStem® to Treat Heart Attacks
Principal investigator · Completed · Phase 1
Healios K.K.
- 2019–2020
Study director · Completed · Phase 2
Diasome Pharmaceuticals